Vaez H, Soraya H, Garjani A, Gholikhani T
Adv Pharm Bull. 2023; 13(1):36-47.
PMID: 36721803
PMC: 9871286.
DOI: 10.34172/apb.2023.004.
Elrakaybi A, Laubner K, Zhou Q, Hug M, Seufert J
Mol Metab. 2022; 64:101549.
PMID: 35863639
PMC: 9352970.
DOI: 10.1016/j.molmet.2022.101549.
Lee J, Kwon Y, Kim H, Shin N, Son H, Cheong C
Mol Cells. 2021; 45(3):134-147.
PMID: 34887364
PMC: 8926863.
DOI: 10.14348/molcells.2021.0074.
Zhang F, Feng J, Zhang J, Kang X, Qian D
Exp Ther Med. 2020; 20(6):280.
PMID: 33200005
PMC: 7664594.
DOI: 10.3892/etm.2020.9410.
Wu S, Zou M
Int J Mol Sci. 2020; 21(14).
PMID: 32679729
PMC: 7404275.
DOI: 10.3390/ijms21144987.
New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis.
Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J
Redox Biol. 2018; 20:247-260.
PMID: 30384259
PMC: 6205410.
DOI: 10.1016/j.redox.2018.09.025.
Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms.
Mancini S, Boyd D, Katwan O, Strembitska A, Almabrouk T, Kennedy S
Sci Rep. 2018; 8(1):5276.
PMID: 29588466
PMC: 5869674.
DOI: 10.1038/s41598-018-23420-4.
Roscovitine protects murine Leydig cells from lipopolysaccharide-induced inflammation.
Xie T, Hu G, Dong B, Yan Y, Liu M, Yao X
Exp Ther Med. 2017; 13(5):2169-2176.
PMID: 28565824
PMC: 5443261.
DOI: 10.3892/etm.2017.4239.
AMP-Activated Protein Kinase: An Ubiquitous Signaling Pathway With Key Roles in the Cardiovascular System.
Salt I, Grahame Hardie D
Circ Res. 2017; 120(11):1825-1841.
PMID: 28546359
PMC: 5447810.
DOI: 10.1161/CIRCRESAHA.117.309633.
Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation.
Mancini S, White A, Bijland S, Rutherford C, Graham D, Richter E
Mol Cell Endocrinol. 2016; 440:44-56.
PMID: 27840174
PMC: 5228585.
DOI: 10.1016/j.mce.2016.11.010.
The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice.
Greig F, Ewart M, McNaughton E, Cooney J, Spickett C, Kennedy S
Vascul Pharmacol. 2015; 74:93-102.
PMID: 26196300
PMC: 4673085.
DOI: 10.1016/j.vph.2015.07.010.
AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
El Hadri K, Denoyelle C, Ravaux L, Viollet B, Foretz M, Friguet B
PLoS One. 2015; 10(7):e0132498.
PMID: 26162096
PMC: 4498592.
DOI: 10.1371/journal.pone.0132498.
Differential Role of Leptin and Adiponectin in Cardiovascular System.
Ghantous C, Azrak Z, Hanache S, Abou-Kheir W, Zeidan A
Int J Endocrinol. 2015; 2015:534320.
PMID: 26064110
PMC: 4433709.
DOI: 10.1155/2015/534320.
Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.
Mak A, Kow N
Biomed Res Int. 2014; 2014:178721.
PMID: 24790989
PMC: 3984775.
DOI: 10.1155/2014/178721.
Perivascular fat, AMP-activated protein kinase and vascular diseases.
Almabrouk T, Ewart M, Salt I, Kennedy S
Br J Pharmacol. 2014; 171(3):595-617.
PMID: 24490856
PMC: 3969075.
DOI: 10.1111/bph.12479.
Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE-deficient mice.
Doddapattar P, Radovic B, Patankar J, Obrowsky S, Jandl K, Nusshold C
Mol Nutr Food Res. 2013; 57(10):1718-28.
PMID: 23650230
PMC: 3771820.
DOI: 10.1002/mnfr.201200794.
AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6.
Gongol B, Marin T, Peng I, Woo B, Martin M, King S
Proc Natl Acad Sci U S A. 2013; 110(8):3161-6.
PMID: 23382195
PMC: 3581905.
DOI: 10.1073/pnas.1222051110.
Mitochondrial reactive oxygen species enhance AMP-activated protein kinase activation in the endothelium of patients with coronary artery disease and diabetes.
Mackenzie R, Salt I, Miller W, Logan A, Ibrahim H, Degasperi A
Clin Sci (Lond). 2012; 124(6):403-11.
PMID: 23057846
PMC: 3903000.
DOI: 10.1042/CS20120239.
PKC-dependent human monocyte adhesion requires AMPK and Syk activation.
Chang M, Huang D, Ho F, Huang K, Lin W
PLoS One. 2012; 7(7):e40999.
PMID: 22848421
PMC: 3405105.
DOI: 10.1371/journal.pone.0040999.
AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.
Srivastava R, Pinkosky S, Filippov S, Hanselman J, Cramer C, Newton R
J Lipid Res. 2012; 53(12):2490-514.
PMID: 22798688
PMC: 3494254.
DOI: 10.1194/jlr.R025882.